Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.

Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, Li W, Shenoy N, Giricz O, Choudhary G, Yu Y, Ko YA, Izquierdo MC, Park AS, Vallumsetla N, Laurence R, Lopez R, Suzuki M, Pullman J, Kaner J, Gartrell B, Hakimi AA, Greally JM, Patel B, Benhadji K, Pradhan K, Verma A, Susztak K.

J Biol Chem. 2017 Jan 20;292(3):837-846. doi: 10.1074/jbc.M116.745208. Epub 2016 Dec 1.

PMID:
27909050
2.

DNA Methylation Analysis: Choosing the Right Method.

Kurdyukov S, Bullock M.

Biology (Basel). 2016 Jan 6;5(1). pii: E3. doi: 10.3390/biology5010003. Review.

3.

COBRA-Seq: Sensitive and Quantitative Methylome Profiling.

Varinli H, Statham AL, Clark SJ, Molloy PL, Ross JP.

Genes (Basel). 2015 Oct 23;6(4):1140-63. doi: 10.3390/genes6041140.

4.

Hydroxymethylation of DNA: an epigenetic marker.

Richa R, Sinha RP.

EXCLI J. 2014 May 27;13:592-610. eCollection 2014. Review. No abstract available.

5.

Post-conversion targeted capture of modified cytosines in mammalian and plant genomes.

Li Q, Suzuki M, Wendt J, Patterson N, Eichten SR, Hermanson PJ, Green D, Jeddeloh J, Richmond T, Rosenbaum H, Burgess D, Springer NM, Greally JM.

Nucleic Acids Res. 2015 Jul 13;43(12):e81. doi: 10.1093/nar/gkv244. Epub 2015 Mar 26.

6.

Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.

Rosenblum JM, Wijetunga NA, Fazzari MJ, Krailo M, Barkauskas DA, Gorlick R, Greally JM.

Epigenetics. 2015;10(1):31-9. doi: 10.4161/15592294.2014.989084. Epub 2015 Jan 23.

7.

AFSM sequencing approach: a simple and rapid method for genome-wide SNP and methylation site discovery and genetic mapping.

Xia Z, Zou M, Zhang S, Feng B, Wang W.

Sci Rep. 2014 Dec 3;4:7300. doi: 10.1038/srep07300.

8.

DNA methylation is developmentally regulated for genes essential for cardiogenesis.

Chamberlain AA, Lin M, Lister RL, Maslov AA, Wang Y, Suzuki M, Wu B, Greally JM, Zheng D, Zhou B.

J Am Heart Assoc. 2014 Jun 19;3(3):e000976. doi: 10.1161/JAHA.114.000976.

9.

Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.

Hu CY, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat TD, Suzuki M, Pullman J, Liu XS, Greally JM, Susztak K, Verma A.

Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.

10.

An integrated platform for bovine DNA methylome analysis suitable for small samples.

Shojaei Saadi HA, O'Doherty AM, Gagné D, Fournier É, Grant JR, Sirard MA, Robert C.

BMC Genomics. 2014 Jun 9;15:451. doi: 10.1186/1471-2164-15-451.

11.

Next generation sequencing: advances in characterizing the methylome.

Taylor KH, Shi H, Caldwell CW.

Genes (Basel). 2010 Jul 1;1(2):143-65. doi: 10.3390/genes1020143.

12.

HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.

Bartholdy B, Christopeit M, Will B, Mo Y, Barreyro L, Yu Y, Bhagat TD, Okoye-Okafor UC, Todorova TI, Greally JM, Levine RL, Melnick A, Verma A, Steidl U.

J Clin Invest. 2014 Mar;124(3):1158-67.

13.

Lsh regulates LTR retrotransposon repression independently of Dnmt3b function.

Dunican DS, Cruickshanks HA, Suzuki M, Semple CA, Davey T, Arceci RJ, Greally J, Adams IR, Meehan RR.

Genome Biol. 2013 Dec 24;14(12):R146. doi: 10.1186/gb-2013-14-12-r146.

14.

Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes.

Malinge S, Chlon T, Doré LC, Ketterling RP, Tallman MS, Paietta E, Gamis AS, Taub JW, Chou ST, Weiss MJ, Crispino JD, Figueroa ME.

Blood. 2013 Oct 3;122(14):e33-43. doi: 10.1182/blood-2013-05-503011. Epub 2013 Aug 26.

15.

Combining genomic and proteomic approaches for epigenetics research.

Han Y, Garcia BA.

Epigenomics. 2013 Aug;5(4):439-52. doi: 10.2217/epi.13.37. Review.

16.

Large, male germ cell-specific hypomethylated DNA domains with unique genomic and epigenomic features on the mouse X chromosome.

Ikeda R, Shiura H, Numata K, Sugimoto M, Kondo M, Mise N, Suzuki M, Greally JM, Abe K.

DNA Res. 2013 Dec;20(6):549-65. doi: 10.1093/dnares/dst030. Epub 2013 Jul 15.

17.

Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes.

Reddington JP, Perricone SM, Nestor CE, Reichmann J, Youngson NA, Suzuki M, Reinhardt D, Dunican DS, Prendergast JG, Mjoseng H, Ramsahoye BH, Whitelaw E, Greally JM, Adams IR, Bickmore WA, Meehan RR.

Genome Biol. 2013 Mar 25;14(3):R25. doi: 10.1186/gb-2013-14-3-r25.

18.

Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.

Heuck CJ, Mehta J, Bhagat T, Gundabolu K, Yu Y, Khan S, Chrysofakis G, Schinke C, Tariman J, Vickrey E, Pulliam N, Nischal S, Zhou L, Bhattacharyya S, Meagher R, Hu C, Maqbool S, Suzuki M, Parekh S, Reu F, Steidl U, Greally J, Verma A, Singhal SB.

J Immunol. 2013 Mar 15;190(6):2966-75. doi: 10.4049/jimmunol.1202493. Epub 2013 Feb 13.

19.

DNA methylation analysis in human cancer.

O'Sullivan E, Goggins M.

Methods Mol Biol. 2013;980:131-56. doi: 10.1007/978-1-62703-287-2_7.

20.

Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers.

Olkhov-Mitsel E, Bapat B.

Cancer Med. 2012 Oct;1(2):237-60. doi: 10.1002/cam4.22. Epub 2012 Sep 14. Review.

Supplemental Content

Support Center